Status:
UNKNOWN
Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative Care
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Solid Cancer in a Palliative Situation With Ascites
Eligibility:
All Genders
18+ years
Brief Summary
Current recommendations do not recommend the concomitant administration of albumin after ascites puncture in patients with ascites neoplasia unlike cirrhotic ascites. The etiology of ascites in cancer...
Detailed Description
According to the recommendations, each ascites fluid must be sent for biochemical and bacteriological analysis. Demonstrate the high gradient proportion (percent only, no threshold of significance re...
Eligibility Criteria
Inclusion
- Patient over 18 years of age followed for a solid cancer in a palliative metastatic situation who had a puncture of ascites.
Exclusion
- Minor patient
- Known cirrhosis
Key Trial Info
Start Date :
December 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03463655
Start Date
December 21 2017
End Date
April 1 2018
Last Update
March 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli Calmettes
Marseille, Bouches Du Rhone, France, 13009